StockNews.AI
ARCT
StockNews.AI
176 days

Arcturus Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on March 6, 2025

1. ARCT to release Q4 and full-year 2024 earnings on March 6 post-market. 2. A conference call and webcast set for 4:30 p.m. ET to discuss results.

-3.77%Current Return
VS
-0.5%S&P 500
$16.6902/24 04:17 PM EDTEvent Start

$16.0602/25 10:52 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Neutral?

The scheduled earnings release is a routine event. Historically, such announcements create short-term volatility without a consistent directional bias until actual results are known.

How important is it?

Earnings reports are pivotal market events that can moderately impact ARCT’s price as investors adjust expectations based on performance, even if the event is anticipated.

Why Short Term?

Earnings announcements typically influence investor sentiment and stock price in the immediate period surrounding the event.

Related Companies

SAN DIEGO--(BUSINESS WIRE)---- $ARCT #ClinicalTrial--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that it will release its financial results for the quarter and year ended December 31, 2024 after the market close on Thursday, March 6 and will also host a conference call and webcast at 4:30 p.m. Eastern Time.

Related News